Chinoy Jenai, Meller Charlotte, de Wet Heidi
Bedford Hospital South Wing, Kempston Road, Bedford MK42 9DJ, UK.
Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, UK.
Int J Mol Sci. 2025 Sep 20;26(18):9211. doi: 10.3390/ijms26189211.
Since the first paper published by Susan Cole in 1990 detailing multidrug resistance mediated by ABCC1/MRP1, research into the C-subfamily of ATP-binding cassette transporters has continued to uncover a wide range of functionally divergent proteins. However, several orphan transporters remain in the C-subfamily, and the physiological function and substrates of ABCC5, ABCC11, and ABCC12 remain elusive. This review explores the emerging understanding of human ABCC5. Unlike other ABC transporters with well-defined drug export functions, ABCC5's physiological roles remain only partially understood. While it is known for its involvement in multidrug resistance in cancers, recent studies suggest broader implications in development, metabolism, neurobiology, and male fertility. ABCC5 exports various endogenous substrates, including cyclic nucleotides (cAMP and cGMP), glutamate conjugates like NAAG, and possibly haem. Knockout models in mice, zebrafish, and sea urchins reveal ABCC5's role in gut formation, brain function, eye development, and iron metabolism. In mice, its deletion results in lower adipose tissue mass, enhanced insulin sensitivity, and neurobehavioral changes resembling schizophrenia, highlighting its role in glutamatergic signalling and circadian regulation. Functionally, ABCC5 appears to impact adipocyte differentiation and GLP-1 release, implicating it in type 2 diabetes susceptibility in humans. Structural studies using human ABCC5 revealed a novel autoinhibitory mechanism involving a peptide segment (C46-S64) that blocks substrate binding, offering new potential for selective inhibitor development. However, this review emphasises caution in targeting ABCC5 for cancer therapy due to its underappreciated physiological function(s), particularly in the brain and male reproductive system. Understanding ABCC5's substrate specificity, regulatory mechanisms, and functional redundancy with its paralog ABCC12 remains critical for successful therapeutic strategies in humans.
自1990年苏珊·科尔发表第一篇详细阐述由ABCC1/MRP1介导的多药耐药性的论文以来,对ATP结合盒转运蛋白C亚家族的研究不断发现一系列功能各异的蛋白质。然而,C亚家族中仍存在几种孤儿转运蛋白,ABCC5、ABCC11和ABCC12的生理功能及底物仍不清楚。本综述探讨了对人类ABCC5的新认识。与其他具有明确药物外排功能的ABC转运蛋白不同,ABCC5的生理作用仍仅部分为人所知。虽然它因参与癌症多药耐药性而闻名,但最近的研究表明其在发育、代谢、神经生物学和男性生育方面有更广泛的影响。ABCC5可外排多种内源性底物,包括环核苷酸(cAMP和cGMP)、如NAAG的谷氨酸共轭物,以及可能的血红素。小鼠、斑马鱼和海胆的基因敲除模型揭示了ABCC5在肠道形成、脑功能、眼睛发育和铁代谢中的作用。在小鼠中,其缺失导致脂肪组织量减少、胰岛素敏感性增强以及类似于精神分裂症的神经行为变化,突出了其在谷氨酸能信号传导和昼夜节律调节中的作用。在功能上,ABCC5似乎影响脂肪细胞分化和GLP-1释放,表明它与人类2型糖尿病易感性有关。使用人类ABCC5的结构研究揭示了一种涉及肽段(C46-S64)的新型自抑制机制,该肽段可阻断底物结合,为选择性抑制剂开发提供了新的潜力。然而,由于其未被充分认识的生理功能,特别是在大脑和男性生殖系统中的功能,本综述强调在将ABCC5作为癌症治疗靶点时要谨慎。了解ABCC5的底物特异性、调节机制及其与旁系同源物ABCC12的功能冗余对于人类成功的治疗策略仍然至关重要。